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Kapiti ranch
The 13,000-hectare Kapiti plains ranch, located in Machakos 
county, southern Kenya, was acquired in 1987 by the 
International Laboratory for Research on Animal Diseases—a 
predecessor of the International Livestock Research Institute 
(ILRI)—to produce good-quality, disease-free cattle for 
research purposes, mainly the improved control of East 
Coast fever and African animal trypanosomiasis. The ranch is 
wholly owned by ILRI and registered under Kenya Company 
Laws as a public limited company. The ranch is home to: 2,500 
cattle (mainly of the local Boran breed, with a few Boran-
Friesian crossbreds); 1,200 sheep (a mix of Dorper, Kenyan 
Red Maasai and some crossbreds); and 250 Galla goats native 
to northern Kenya.
Kapiti ranch is located in Kenya’s semi-arid lands (550mm 
average rainfall) at an altitude of 1,650–1,900m above 
sea level. The soils of the ranch are mainly black cotton 
(in the plains) and red cotton (in the ridges); and they 
support diverse savanna grasses: tussock-forming Themeda 
(commonly known as kangaroo or red oat grass); Panicum 
(switchgrass); Chloris (windmill or finger grass); Pennisetum 
(fountain grass); Cenchrus (African foxtail grass); Setaria 
(foxtail or bristle grasses);Acacia (whistling thorn); and 
Balanites trees.
Though the ranch’s pasture is usually adequate for its 
livestock farming, during the dry season water continues to 
be a major constraint to efficient production. Four boreholes  
and nine water pans (the latter largely dependent on rainfall) 
currently supply the ranch with water. A new water pan 
has just been completed, opening up an area with good-to-
excellent pasture.
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Kapiti is home to various wildlife, including giraffes, gazelles, 
antelopes and zebras, as well as predators such as hyenas, 
lions, cheetahs and leopards. Owing to various infrastructural 
developments in the neighbourhood (highways, Konza 
Technocity), Kapiti has become a safe haven for wildlife. This 
presents unique opportunities to include wildlife in research 
projects.
Kapiti farmhouse
Kapiti’s newly renovated farmhouse is now available for 
group retreats and workshops and to scientists conducting 
research on the ranch. Situated in delightful surroundings, 
the charming traditional-style farmhouse can accommodate 
up to 18 people in 9 bedrooms, each with its own 
bathroom. It offers one large and one small meeting room 
and a fully equipped kitchen. Workshops of more than 18 
participants can also be organized.
Other infrastructure on the ranch includes offices, spray 
races, a newly designed cattle crush, two cattle yards, the 
second with an attached laboratory, as well as various 
permanent structures and mobile cattle enclosures 
(bomas) for housing livestock at night. Staff housing is 
available.
Kapiti research
Malignant catarrhal fever vaccination trial
A study of malignant catarrhal fever was developed in 
response to an outbreak of wildebeest-associated malignant 
catarrhal fever on Kapiti ranch in 2014.This fatal cattle 
disease is caused by the alcelaphine herpesvirus 2 which is 
endemic to wildebeest. It is spread to cattle by parturient 
wildebeests (giving or about to give birth), the nasal and 
ocular secretions of young calves, or pastures contaminated 
by these secretions.
A vaccination trial for malignant catarrhal fever was started 
at Kapiti ranch in January 2016, in collaboration with the 
UK Moredun Research Institute and Global Alliance for 
Livestock Veterinary Medicines (GALVmed).A total number 
of 146 steers 8–18 months old were selected for the study. 
Seventy-three animals received the MCF C500 vaccination, 
while the remainder received a placebo.
There were 25 cases of malignant catarrhal fever in the 
study herd between May and July 2016, 3 in the vaccinated 
group and 22 in the unvaccinated group. The difference in the 
proportion of cases in the vaccinated (4%) and unvaccinated 
(30%) groups is statistically significant (p<0.001).The vaccine 
efficacy was estimated to be 86% (95% CI 56–96%).These 
preliminary findings will need to be confirmed in laboratory 
experiments. Further work is planned to assess the current 
control methods for malignant catarrhal fever across Kenya 
and demand for a commercial vaccine.
Genetic variation in responses to foot-and-
mouth disease vaccines
Foot-and-mouth disease (FMD)—a highly contagious disease 
of cloven-hooved animals—creates an enormous economic 
burden in many regions where the disease is endemic.
Control of the disease is achieved by vaccination and the 
control of animal movement. However, the requirement 
to revaccinate animals at 4–6 month intervals makes it 
prohibitively expensive for many livestock keepers in low- 
and middle-income countries.
That responses to vaccination vary among animals may 
suggest the influence of genotype on their immune 
responsiveness. Identifying genetic markers, or genes 
associated with either strong or weak responses, could 
provide tools with which to select ‘good responders’ with 
possibly enhanced disease resistance. This research could 
both identify animals most resistant to disease and point to 
new ways to improve the efficacy of vaccination.
The project will select 200 unvaccinated calves at Kapiti 
Ranch from September 2016–2017. Immune responses 
to vaccination will be assessed for four months following 
vaccination. This information will be used to:
• Estimate the variation in antibody response within and 
between sire groups of Boran cattle to FMD vaccination;
• Develop a mathematical model of the decay of protective 
antibodies with which scientists estimate the fraction of 
susceptible animals at a given time after vaccination and 
how this varies among different sire lines;
• Identify the ‘poor’ responders and look for genetic mark-
ers or sire lines associated with the poor response; and
• Identify MHC I haplotypes associated with ‘good’ or ‘bad’ 
antibody responses.
• Ninety-four calves have been selected so far. All the 
calves were fitted with radio frequency identification tags 
and were vaccinated against FMD in September 2016.
I
Contact 
Ilona Gluecks  
ILRI, Kenya 
I.Gluecks@cgiar.org
This publication is copyrighted by the International Livestock Research Institute (ILRI). It is licensed for use under the Creative Commons Attribution 4.0 International Licence.                        May 2017
ILRI thanks all donors that globally support its work through their contributions to the CGIAR system
Patron: Professor Peter C Doherty AC, FAA, FRS 
Animal scientist, Nobel Prize Laureate for Physiology or Medicine–1996
Box 30709, Nairobi 00100 Kenya 
Phone  +254 20 422 3000 
Fax      +254 20 422 3001 
Email ilri-kenya@cgiar.org
ilri.org 
better lives through livestock 
 
ILRI is a CGIAR research centre
Box 5689, Addis Ababa, Ethiopia 
Phone +251 11 617 2000 
Fax +251 11 667 6923 
Email ilri-ethiopia@cgiar.org 
ILRI has offices in East Africa • South Asia • Southeast and East Asia • Southern Africa • West Africa
Assessing the main nitrogen loss 
pathways from semi-arid livestock 
systems in East Africa
This research assesses nitrogen losses from cattle bomas 
at Kapiti ranch with state-of-the-art micro-meteorological 
techniques. Gaseous losses of carbon dioxide, methane, nitrous 
oxide and ammonia from the ecosystem into the atmosphere 
are being measured continuously, as are nitrogen losses from 
the soil. This will allow scientists to estimate how much Kapiti’s 
cattle bomas contribute to the ranch’s overall nitrogen budget.
Rift Valley fever vaccine immune 
response trial
Beginning at the end of 2017, in collaboration with The Jenner 
Institute, University of Oxford, and The Pirbright Institute, a 
two-year Rift Valley fever vaccine project will test the capacity 
of Kapiti ranch to serve as a research station for large-scale 
research projects. A non- inferiority trial will be conducted in 
both male and female sheep, goats, cattle and camels—the most 
susceptible species to the Rift Valley fever virus (RVFV) and 
the major targets of livestock vaccination programs in Africa. 
Weaned animals aged at least three months and without previous 
exposure to RVFV will be randomly allocated to vaccination with 
ChAdOx1- GnGc (n=80 per species), Smithburn vaccine (n=80 
per species) or placebo (saline; n=20 per species).The animals 
will be followed for 12 months after their vaccination, and safety 
and immunogenicity endpoints assessed. The primary aim of 
this non-inferiority field trial is to determine the similarities in 
the proportions of animals mounting a detectable neutralizing 
antibody response to RVFV following immunization with the 
ChAdOx1-GnGc and Smithburn vaccines.
Selection and crossbreeding to improve 
sheep productivity and adaptability
The foundation stock of indigenous Red Maasai and Dorper 
sheep were introduced into Kapiti in 1997 for a comparative 
study seeking to increase understanding of the relative ability of 
the two breeds and their crosses to tolerate gastro-intestinal 
worm infestation, specifically Haemonchus contortus. In 2005, 
two parallel programs were initiated and continue to date: (1) a 
selection program seeking to enable improvements in the growth, 
reproductive performance and hardiness of the Red Maasai 
sheep; and (2) a Red Maasai–Dorper crossbreeding program 
producing 50% and 75% Dorper crossbreeds for sale, with the 
genetically superior young rams selected annually and used in 
the flock, and subsequently sold to the neigbouring pastoral 
Maasai herders for breeding. Since 1997, significant amounts of 
research have been undertaken, including: a) genomic studies to 
identify the quantitative trait loci for haemonchus tolerance; b) 
on a participatory definition of breeding objectives; c) estimations 
of the economic value of live weight, conformation and carcass 
traits for the two breeds and their crosses; and d) a simulation of 
the well-adapted and drought-tolerant East African Red Maasai 
breed and its crosses with the Dorper under different local 
environments. Data is routinely collected on growth, reproduction, 
survival performance of these sheep, and studies on the genomic 
selection of young rams, comparative genomics and related fields 
are planned in the future. 
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